1. Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors

   • Wei-hui Liu
   • Nan You
   • Li-jun Tang

   Review 22 November 2012 Pages: 397 - 409

   

2. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort

   • Vito Guarnieri
   • Claudia Battista
   • Alfredo Scillitani

   Original Paper 18 September 2012 Pages: 411 - 422

   

3. Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity

   • Li Wei
   • Fan DongMei
   • Xiong DongSheng

   Original Paper 09 October 2012 Pages: 423 - 434

   

4. HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast

   • Cigdem Ercan
   • Jeroen F. Vermeulen
   • Paul J. van Diest

   Original Paper 25 September 2012 Pages: 435 - 442

   

5. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas

   • Cristina García-Inclán
   • Fernando López
   • Mario A. Hermsen

   Original Paper 11 October 2012 Pages: 443 - 450

   

6. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion

   • Iara F. Kretzer
   • Durvanei A. Maria
   • Raul C. Maranhão

   Original Paper 03 October 2012 Pages: 451 - 460

   

7. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients

   • Jong-Rung Tsai
   • Hui-Min Wang
   • Inn-Wen Chong

   Original Papers 10 October 2012 Pages: 461 - 471

   

8. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development

   • Rahul Bhagat
   • Shilpa Chadaga
   • Lakshmi Krishnamoorthy

   Original Paper 10 October 2012 Pages: 473 - 479